Vyne Therapeutics Inc (NASDAQ:VYNE)
| 2.60 BATS BZX Real-Time Price As of Mar 28 |  0.00 / 0.00%Today’s Change | 1.99 Today|||52-Week Range 14.22 | -3.70% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -4.6M | -14.1M | -29.1M | -51.4M | |
| Depreciation | 0.00 | 4.0K | 8.0K | 22.0K | ||
| Total Other Cash Flow | 65.0K | 705.0K | 1.5M | 2.9M | ||
| Funds From Operations | -4.5M | -13.4M | -27.5M | -48.6M | ||
| Funds From/For Other Operating Expenses | -360.0K | -11.1M | 722.0K | 4.2M | ||
| Net Cash Flow - Operating Activities | -4.2M | -2.3M | -28.2M | -52.7M | ||
| Investing | Increase In Investments | 0.00 | -55.3M | -64.1M | -126.7M | |
| Decrease In Investments | 0.00 | 17.9M | 49.1M | 93.0M | ||
| Capital Expenditures | 0.00 | -31.0K | -27.0K | -140.0K | ||
| Net Cash Flow Investing | 0.00 | -37.5M | -15.1M | -33.9M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 47.7M | 0.00 | 50.4M | 125.9M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | -- | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 867.0K | 0.00 | ||
| Net Cash Flow - Financing | 47.7M | 0.00 | 49.5M | 125.9M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 43.5M | -39.8M | 6.2M | 39.3M | ||
